EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE

6 Months Ended

Mar. 31, 2025

Equity Method Investments and Joint Ventures [Abstract]

EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE

As discussed in Note 5, the Company completed the divestiture of a majority stake in Copeland on May 31, 2023, and received upfront, pre-tax cash proceeds of approximately $9.7 billion and a note receivable with a face value of $2.25 billion, while retaining a 40 percent non-controlling common equity interest in Copeland.

On June 6, 2024, the Company entered into definitive agreements to sell its 40 percent non-controlling common equity interest in Copeland to private equity funds managed by Blackstone for $1.5 billion and its note receivable to Copeland for $1.9 billion, and the transactions were subsequently completed in August 2024. As a result of these transactions, the gain on the sale of the Company's non-controlling common equity interest in Copeland and the historical equity method losses, which were recorded since May 2023 in Other deductions, net, have been reclassified and are now reported as discontinued operations for all periods presented (see Note 5).

For the three and six months ended March 31, 2024 the Company recognized non-cash interest income on the note receivable of $31 and $62, respectively which is reported in Interest income from related party within continuing operations.

Summarized financial information for Copeland for the three and six months ended March 31, 2024 is as follows.


	Three Months Ended March 31,		Six Months Ended March 31,
	2024		2024
Net sales	$	1,175	$	2,199
Gross profit	$	412	$	757
Income (loss) from continuing operations	$	(147)	$	(240)
Net income (loss)	$	(147)	$	(240)
Net income (loss) attributable to shareholders	$	(148)	$	(238)